Gurgaon Samachar

Heart Pump Device CAGR, Market Dynamics, Competitive Landscape and Market Insights

 Breaking News
  • No posts were found

Heart Pump Device CAGR, Market Dynamics, Competitive Landscape and Market Insights

January 05
16:06 2022
Heart Pump Device CAGR, Market Dynamics, Competitive Landscape and Market Insights

Heart Pump Devices Market By Product (Ventricular Assist Devices- Left Ventricular Assist Devices (LVAD), Percutaneous Ventricular Assist Devices (PVAD), Biventricular Ventricular Assist Devices (BIVAD), Right Ventricular Assist Devices (RVAD), And Intra-Aortic Balloon Pumps, Total Artificial Hearts), By Type (Implanted Heart Pump Device, Extracorporeal Heart Pump Device), By Therapy (Bridge-To-Transplant (BTT), Bridge-To-Candidacy (BTC), Destination Therapy (DT)), By End-User (Hospitals, Cardiac Centers, Ambulatory Surgical Centers), By Geography is expected to grow at a steady CAGR Forecast till 2026 owing to Extensive Products in Pipeline and Cardiovascular Disease (CVDS) Prevalence.

 

Global Heart Pump Devices Market was valued at USD 2.37 billion in 2020, growing at a CAGR of 15.24% during the forecast period from 2021 to 2026, to reach USD 6.36 billion by 2026. The demand for Heart Pump Devices is primarily motivated by the increase in cardiovascular disease (CVDs) prevalence, rise in geriatric population, and various companies with products in their pipeline phase. Heart Pump devices were found to be extremely beneficial in heart failure cases in COVID-19 which further pushed for the demand for these devices in the pandemic situation. Due to a scarcity of heart suppliers, cardiac pumps are an optimal solution that encourages Global market expansion. Factors such as the high cost of the pump and a low repayment scenario in developing countries are nevertheless projected to inhibit the growth of the market.

 

Download Sample Report– Heart Pump Device Market Report

 

Heart Pump Device Market Companies

  • Abbott Laboratories
  • Abiomed, Inc.
  • Teleflex Incorporated
  • SynCardia Systems, LLC
  • Jude Medical Inc
  • CARMAT
  • And many others

 

Heart Pump Devices Market Dynamics

As per the Centres for Disease Control and Prevention (CDC), in 2020, certain risk factors like coronary artery disease (CAD), heart attacks, diabetes, high blood pressure, and obesity increases the risk for heart failure. According to a report from the American Heart Association, 2020, the prevalence of heart failure continues to increase over time, with the aging of the population. An estimated 6.2 million American adults ≥20 years of age had heart failure between 2013 and 2016, compared with an estimated 5.7 million between 2009 and 2012.

 

Heart Pump Devices Market Analysis

Heart Pump Devices by Product (Ventricular Assist Devices- Left Ventricular Assist Devices (LVAD), Percutaneous Ventricular Assist Devices (PVAD), Biventricular Ventricular Assist Devices (BIVAD), Right Ventricular Assist Devices (RVAD), and Intra-Aortic Balloon Pumps, Total Artificial Hearts), Heart Pump Devices market by Type (Implanted Heart Pump Device, Extracorporeal Heart Pump Device), Heart Pump Devices market by Therapy (Bridge-To-Transplant (BTT), Bridge-To-Candidacy (BTC), Destination Therapy (DT)), Heart Pump Devices market by End-User (Hospitals, Cardiac Centres, Ambulatory Surgical Centres), and Heart Pump Devices market by Geography (North America, Europe, Asia-Pacific, and Rest of the World).

 

Heart Pump Devices Market- North America

North America is expected to dominate the overall Heart Pump Devices market during the forecast period. This domination is due to the growing demand for advanced technologies in Heart Pump Devices, the increasing chronic disease in the region is driving the regional growth.

According to the Centers for Disease Control and Prevention (CDC), in 2020, about 6.2 million adults in the United States have heart failure. Heart disease is the leading cause of death for men, women, and people of most racial and ethnic groups in the United States. About 655,000 Americans die from heart disease each year—that’s 1 in every 4 deaths.

Further, in the United States, the rising adoption of these devices, the high prevalence of CVDs, the growing number of research and development activities to improve current technologies, and the limited availability of donor hearts for transplants. This situation is giving rise to a critical need for Heart Pump Devices for the treatment of the disease.

 

Request sample report- Heart Pump Devices Competitive Landscape

 

Table of content

  1. Heart Pump Devices Market Report Introduction
  2. Heart Pump Devices Market Executive summary
  3. Regulatory and Patent Analysis
  4. Heart Pump Devices Market Key factors analysis
  5. COVID-19 Impact Analysis on Heart Pump Devices Market
  6. Heart Pump Devices Market layout
  7. Heart Pump Devices Global Company Share Analysis – Key 3-5 Companies
  8. Heart Pump Devices Company and Product Profiles
  9. Project Approach
  10. KOL Views
  11. DelveInsight Capabilities
  12. Disclaimer
  13. About DelveInsight

 

About DelveInsight

DelveInsight is a Business Consulting and Market research company, providing expert business solutions for life science vertical and offering quintessential advisory services in the areas of R&D, Strategy Formulation, Operations, Competitive Intelligence, Competitive Landscaping, and Mergers & Acquisitions.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: Send Email
Phone: +919650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/

Recent Posts

Acute-on-Chronic Liver Failure Market to Witness Growth by 2032, Estimates DelveInsight | Grifols Therapeutics, Versantis AG, HepaStem

Read Full Article

Categories